US Stock MarketDetailed Quotes

OTLK Outlook Therapeutics

Watchlist
  • 7.700
  • +0.020+0.26%
Trading Aug 16 13:22 ET
182.15MMarket Cap-1307P/E (TTM)

Outlook Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
-4.46%-56.67M
-14.02%-10.25M
Net income from continuing operations
314.80%44.41M
-1,617.52%-114.29M
40.10%-11.18M
10.70%-58.98M
9.44%-12.99M
-17.87%-20.68M
66.23%-6.65M
-29.04%-18.66M
-24.24%-66.05M
-7.02%-14.35M
Operating gains losses
-295,839.99%-56M
5,075,432.12%83.74M
-90.34%50.79K
-11.61%537.74K
-37.62%-5.44K
108.69%18.94K
-105.31%-1.65K
-34.19%525.89K
22.04%608.35K
98.68%-3.96K
Depreciation and amortization
156.18%28.67K
156.29%28.2K
161.60%28.2K
-78.41%44.19K
-78.21%11.22K
-78.17%11.19K
-78.47%11K
-78.81%10.78K
-21.91%204.69K
1.57%51.47K
Other non cash items
--0
--1.69M
-27.58%993K
102.00%5.13M
724.33%3.76M
--0
--0
170.42%1.37M
643.16%2.54M
79.62%455.64K
Change In working capital
-156.72%-1.78M
55.84%-1.26M
-164.98%-4.2M
382.19%4.75M
-189.78%-1.99M
156.28%3.14M
-474.19%-2.86M
608.97%6.46M
76.21%-1.68M
-26.30%2.22M
-Change in prepaid assets
-2,764.49%-3.04M
-595.95%-524.12K
-410.12%-2.45M
184.61%2.62M
30.80%1.79M
103.38%113.96K
90.67%-75.31K
376.18%788.51K
-78.78%-3.09M
-73.56%1.37M
-Change in payables and accrued expense
-60.65%1.28M
73.60%-731.16K
-130.84%-1.75M
63.40%2.37M
-543.20%-3.8M
248.51%3.26M
-275.18%-2.77M
370.87%5.68M
126.40%1.45M
139.74%857.98K
-Change in other current assets
90.11%-22.97K
----
----
---208.2K
--24.02K
---232.22K
----
----
--0
--0
-Change in other current liabilities
43.50%-2.22K
--0
--0
37.01%-27K
--0
63.94%-3.93K
-11.06%-11.64K
-11.27%-11.42K
71.50%-42.85K
-11.26%-11.21K
Cash from discontinued investing activities
Operating cash flow
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
-4.46%-56.67M
-14.02%-10.25M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
30.69%4.31M
9,501.66%56.14M
-100.01%-3.18K
-17.83%48.97M
49.08%2.42M
129.16%3.3M
-122.90%-597.13K
-34.23%43.85M
6.05%59.59M
-56.93%1.63M
Net issuance payments of debt
--0
62.48%-1.08K
-100.02%-3.18K
952.41%19.77M
45.79%-3.08K
99.97%-2.98K
99.06%-2.89K
106.20%19.78M
-136.77%-2.32M
71.17%-5.69K
Net common stock issuance
30.57%4.31M
16,647.34%56.14M
--0
-51.81%30.02M
48.75%2.43M
1,025.98%3.3M
-112.44%-339.28K
-57.27%24.64M
34.57%62.31M
-56.92%1.63M
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-94.27%205.85K
--0
Net other financing activities
----
----
----
-37.32%-823.89K
--0
--0
---254.96K
5.18%-568.93K
-7,370.12%-600K
--0
Cash from discontinued financing activities
Financing cash flow
30.69%4.31M
9,501.66%56.14M
-100.01%-3.18K
-17.83%48.97M
49.08%2.42M
129.16%3.3M
-122.90%-597.13K
-34.23%43.85M
6.05%59.59M
-56.93%1.63M
Net cash flow
Beginning cash position
8.25%47.23M
-80.21%10.36M
34.46%23.39M
20.17%17.4M
29.54%33.71M
-25.32%43.63M
-25.39%52.34M
20.17%17.4M
15.49%14.48M
32.14%26.02M
Current changes in cash
-53.27%-15.2M
523.25%36.87M
-137.30%-13.04M
105.35%6M
-19.62%-10.32M
69.39%-9.92M
25.71%-8.71M
-37.23%34.94M
50.39%2.92M
-65.39%-8.62M
End cash Position
-5.00%32.02M
8.25%47.23M
-80.21%10.36M
34.46%23.39M
34.46%23.39M
29.54%33.71M
-25.32%43.63M
-25.39%52.34M
20.17%17.4M
20.17%17.4M
Free cash flow
-47.64%-19.51M
-137.44%-19.27M
-46.41%-13.03M
24.18%-42.97M
-24.30%-12.74M
37.36%-13.22M
43.39%-8.11M
19.01%-8.9M
-4.46%-56.67M
-14.02%-10.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -47.64%-19.51M-137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M-4.46%-56.67M-14.02%-10.25M
Net income from continuing operations 314.80%44.41M-1,617.52%-114.29M40.10%-11.18M10.70%-58.98M9.44%-12.99M-17.87%-20.68M66.23%-6.65M-29.04%-18.66M-24.24%-66.05M-7.02%-14.35M
Operating gains losses -295,839.99%-56M5,075,432.12%83.74M-90.34%50.79K-11.61%537.74K-37.62%-5.44K108.69%18.94K-105.31%-1.65K-34.19%525.89K22.04%608.35K98.68%-3.96K
Depreciation and amortization 156.18%28.67K156.29%28.2K161.60%28.2K-78.41%44.19K-78.21%11.22K-78.17%11.19K-78.47%11K-78.81%10.78K-21.91%204.69K1.57%51.47K
Other non cash items --0--1.69M-27.58%993K102.00%5.13M724.33%3.76M--0--0170.42%1.37M643.16%2.54M79.62%455.64K
Change In working capital -156.72%-1.78M55.84%-1.26M-164.98%-4.2M382.19%4.75M-189.78%-1.99M156.28%3.14M-474.19%-2.86M608.97%6.46M76.21%-1.68M-26.30%2.22M
-Change in prepaid assets -2,764.49%-3.04M-595.95%-524.12K-410.12%-2.45M184.61%2.62M30.80%1.79M103.38%113.96K90.67%-75.31K376.18%788.51K-78.78%-3.09M-73.56%1.37M
-Change in payables and accrued expense -60.65%1.28M73.60%-731.16K-130.84%-1.75M63.40%2.37M-543.20%-3.8M248.51%3.26M-275.18%-2.77M370.87%5.68M126.40%1.45M139.74%857.98K
-Change in other current assets 90.11%-22.97K-----------208.2K--24.02K---232.22K----------0--0
-Change in other current liabilities 43.50%-2.22K--0--037.01%-27K--063.94%-3.93K-11.06%-11.64K-11.27%-11.42K71.50%-42.85K-11.26%-11.21K
Cash from discontinued investing activities
Operating cash flow -47.64%-19.51M-137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M-4.46%-56.67M-14.02%-10.25M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 30.69%4.31M9,501.66%56.14M-100.01%-3.18K-17.83%48.97M49.08%2.42M129.16%3.3M-122.90%-597.13K-34.23%43.85M6.05%59.59M-56.93%1.63M
Net issuance payments of debt --062.48%-1.08K-100.02%-3.18K952.41%19.77M45.79%-3.08K99.97%-2.98K99.06%-2.89K106.20%19.78M-136.77%-2.32M71.17%-5.69K
Net common stock issuance 30.57%4.31M16,647.34%56.14M--0-51.81%30.02M48.75%2.43M1,025.98%3.3M-112.44%-339.28K-57.27%24.64M34.57%62.31M-56.92%1.63M
Proceeds from stock option exercised by employees --------------0-----------------94.27%205.85K--0
Net other financing activities -------------37.32%-823.89K--0--0---254.96K5.18%-568.93K-7,370.12%-600K--0
Cash from discontinued financing activities
Financing cash flow 30.69%4.31M9,501.66%56.14M-100.01%-3.18K-17.83%48.97M49.08%2.42M129.16%3.3M-122.90%-597.13K-34.23%43.85M6.05%59.59M-56.93%1.63M
Net cash flow
Beginning cash position 8.25%47.23M-80.21%10.36M34.46%23.39M20.17%17.4M29.54%33.71M-25.32%43.63M-25.39%52.34M20.17%17.4M15.49%14.48M32.14%26.02M
Current changes in cash -53.27%-15.2M523.25%36.87M-137.30%-13.04M105.35%6M-19.62%-10.32M69.39%-9.92M25.71%-8.71M-37.23%34.94M50.39%2.92M-65.39%-8.62M
End cash Position -5.00%32.02M8.25%47.23M-80.21%10.36M34.46%23.39M34.46%23.39M29.54%33.71M-25.32%43.63M-25.39%52.34M20.17%17.4M20.17%17.4M
Free cash flow -47.64%-19.51M-137.44%-19.27M-46.41%-13.03M24.18%-42.97M-24.30%-12.74M37.36%-13.22M43.39%-8.11M19.01%-8.9M-4.46%-56.67M-14.02%-10.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg